Search Results

BioCapital

MCRA Supports Onkos Surgical with First FDA De Novo Approval for Antibacterial Coating for Implants

MCRA, the leading privately held independent medical device, diagnostics, and biologics Clinical Research Organization (CRO) and advisory firm is pleased to announce its role in the U.S. Food and Drug Administration’s (FDA) De Novo granting for Onkos Surgical’s antibacterial coating for tumor and revision orthopedic implants.

June 20, 2024

·

4 min read

Pharm Country

Onkos Surgical Presents at the Canaccord Genuity 2024 Musculoskeletal Healthcare Conference

Onkos Surgical presented Monday, February 12th at the Canaccord Genuity Musculoskeletal Conference in San Francisco.

February 13, 2024

·

4 min read

Pharm Country

Onkos Surgical to Present at Canaccord Genuity’s 2024 Musculoskeletal Conference

Onkos Surgical, Inc. announced today that it will present at Canaccord Genuity’s 2024 Musculoskeletal Conference in San Francisco, CA. Patrick Treacy, Onkos CEO and co-founder, is scheduled to present a corporate overview and update on February 12th, at the Westin St. Francis at 11:00 a.m. PST.

February 5, 2024

·

2 min read

Pharm Country

Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants

Onkos Surgical, an orthopaedic company founded to address the complex clinical challenges associated with bone loss due to tumor, trauma, and revision surgery, announced that the U.S. Food & Drug Administration (FDA) granted the company a De Novo approval for its novel antibacterial coated implants.

April 8, 2024

·

4 min read

Pharm Country

Onkos Surgical Announces Expanded Capability in Pediatric Musculoskeletal Oncology and Unveils New Manufacturing and Innovation Center

Onkos Surgical announced its launch of the JTS Extendible Prosthesis, a novel growing implant designed for pediatric patients with bone cancer, and unveiled its new, state-of-the-art manufacturing and R&D innovation center at its Parsippany, NJ headquarters to support the integration and growth of the technology.

July 19, 2023

·

4 min read

FDA

Onkos Surgical Receives FDA 510(k) Clearance for 3D Printed, Patient-Specific Pelvic Reconstruction System

Onkos Surgical today announced that it has received 510(k) clearance for its My3D® Personalized Pelvic Reconstruction system.

July 14, 2022

·

4 min read

Business

THINK Surgical Enters Distribution Agreement with Zimmer Biomet

THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, announced that it has entered into a Limited Exclusive Distribution And Supply Agreement with Zimmer Biomet, a global medical technology leader.

June 12, 2024

·

3 min read

BioMidwest

MOLLI Surgical Unveils OncoPen, a New Surgical Tool for Empowering Precision and Confidence in the Operating Room

MOLLI Surgical continues to push the boundaries of surgical care with the launch of OncoPen™, a minimally invasive surgical tool designed to empower surgeons and improve outcomes for patients affected with breast cancer.

April 9, 2024

·

3 min read

Press Releases

RTI Surgical Transforms into Evergen, a Leading CDMO in Regenerative Medicine

December 17, 2024

·

2 min read

Press Releases

Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant

December 16, 2024

·

4 min read